AnaptysBio Other Current Assets vs Property Plant And Equipment Net Analysis

ANAB Stock

USD 25.47 0.13 0.51%

AnaptysBio financial indicator trend analysis is way more than just evaluating AnaptysBio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AnaptysBio is a good investment. Please check the relationship between AnaptysBio Other Current Assets and its Property Plant And Equipment Net accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.

Other Current Assets vs Property Plant And Equipment Net

Other Current Assets vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AnaptysBio Other Current Assets account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have strong relationship.

The correlation between AnaptysBio's Other Current Assets and Property Plant And Equipment Net is 0.73. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of AnaptysBio, assuming nothing else is changed. The correlation between historical values of AnaptysBio's Other Current Assets and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of AnaptysBio are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Other Current Assets i.e., AnaptysBio's Other Current Assets and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

0.73

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most indicators from AnaptysBio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AnaptysBio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.At present, AnaptysBio's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 2.57, whereas Tax Provision is forecasted to decline to (4.2 K).

	2021	2022	2023	2024 (projected)
Interest Expense	1.5M	21.1M	18.1M	19.0M
Depreciation And Amortization	468K	7.6M	2.4M	2.8M

Interest Expense Depreciation And Amortization

AnaptysBio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Net Tangible Assets
Total Assets		0.66	0.56	0.82	0.82	0.69	0.8	-0.64	-0.72	0.5	0.66	0.86	-0.18	0.99	0.79	-0.46	0.62	0.75	0.78	0.65	0.64	0.99	0.45	0.79	0.66	0.93
Short Long Term Debt Total	0.66		0.52	0.49	0.28	0.76	0.49	-0.32	-0.58	0.0	0.37	0.72	0.05	0.61	0.35	-0.52	0.75	0.6	0.57	0.74	0.72	0.62	0.26	0.3	0.57	0.64
Other Current Liab	0.56	0.52		0.64	0.08	0.85	0.53	-0.11	-0.96	0.11	0.14	0.44	-0.23	0.56	0.53	-0.28	0.9	0.79	0.91	0.91	0.91	0.57	-0.09	0.46	0.97	0.78
Total Current Liabilities	0.82	0.49	0.64		0.59	0.57	0.87	-0.27	-0.8	0.68	0.3	0.63	-0.11	0.82	0.77	-0.51	0.59	0.8	0.71	0.62	0.6	0.83	0.32	0.7	0.63	0.85
Total Stockholder Equity	0.82	0.28	0.08	0.59		0.17	0.64	-0.67	-0.27	0.6	0.68	0.64	-0.06	0.84	0.62	-0.41	0.08	0.43	0.39	0.11	0.11	0.83	0.6	0.68	0.2	0.64
Property Plant And Equipment Net	0.69	0.76	0.85	0.57	0.17		0.54	-0.35	-0.87	0.06	0.39	0.67	-0.26	0.66	0.55	-0.24	0.98	0.73	0.87	0.98	0.98	0.67	-0.01	0.52	0.89	0.8
Current Deferred Revenue	0.8	0.49	0.53	0.87	0.64	0.54		-0.51	-0.66	0.52	0.53	0.59	-0.12	0.82	0.71	-0.63	0.51	0.65	0.69	0.54	0.52	0.82	0.18	0.68	0.59	0.76
Net Debt	-0.64	-0.32	-0.11	-0.27	-0.67	-0.35	-0.51		0.2	-0.26	-1.0	-0.36	-0.01	-0.68	-0.39	0.27	-0.19	-0.21	-0.46	-0.19	-0.26	-0.68	-0.06	-0.44	-0.3	-0.46
Retained Earnings	-0.72	-0.58	-0.96	-0.8	-0.27	-0.87	-0.66	0.2		-0.35	-0.24	-0.58	0.21	-0.71	-0.66	0.33	-0.91	-0.88	-0.92	-0.93	-0.92	-0.72	-0.07	-0.6	-0.94	-0.89
Accounts Payable	0.5	0.0	0.11	0.68	0.6	0.06	0.52	-0.26	-0.35		0.25	0.31	0.24	0.52	0.41	-0.33	0.05	0.4	0.23	0.09	0.08	0.52	0.26	0.41	0.09	0.46
Cash	0.66	0.37	0.14	0.3	0.68	0.39	0.53	-1.0	-0.24	0.25		0.4	0.01	0.71	0.4	-0.29	0.24	0.24	0.49	0.24	0.3	0.7	0.07	0.45	0.33	0.5
Non Current Assets Total	0.86	0.72	0.44	0.63	0.64	0.67	0.59	-0.36	-0.58	0.31	0.4		-0.23	0.8	0.65	-0.35	0.62	0.57	0.61	0.63	0.59	0.8	0.48	0.68	0.52	0.76
Non Currrent Assets Other	-0.18	0.05	-0.23	-0.11	-0.06	-0.26	-0.12	-0.01	0.21	0.24	0.01	-0.23		-0.16	-0.64	-0.41	-0.23	-0.19	-0.23	-0.23	-0.26	-0.16	-0.31	-0.66	-0.25	-0.27
Cash And Short Term Investments	0.99	0.61	0.56	0.82	0.84	0.66	0.82	-0.68	-0.71	0.52	0.71	0.8	-0.16		0.79	-0.46	0.59	0.75	0.79	0.62	0.62	1.0	0.42	0.79	0.66	0.93
Common Stock Total Equity	0.79	0.35	0.53	0.77	0.62	0.55	0.71	-0.39	-0.66	0.41	0.4	0.65	-0.64	0.79		-0.04	0.51	0.64	0.67	0.53	0.54	0.79	0.44	0.98	0.59	0.8
Common Stock Shares Outstanding	-0.46	-0.52	-0.28	-0.51	-0.41	-0.24	-0.63	0.27	0.33	-0.33	-0.29	-0.35	-0.41	-0.46	-0.04		-0.26	-0.45	-0.32	-0.29	-0.25	-0.47	-0.21	-0.03	-0.27	-0.43
Non Current Liabilities Total	0.62	0.75	0.9	0.59	0.08	0.98	0.51	-0.19	-0.91	0.05	0.24	0.62	-0.23	0.59	0.51	-0.26		0.76	0.86	1.0	0.99	0.6	-0.02	0.46	0.9	0.78
Other Current Assets	0.75	0.6	0.79	0.8	0.43	0.73	0.65	-0.21	-0.88	0.4	0.24	0.57	-0.19	0.75	0.64	-0.45	0.76		0.76	0.79	0.79	0.76	0.42	0.59	0.75	0.91
Other Stockholder Equity	0.78	0.57	0.91	0.71	0.39	0.87	0.69	-0.46	-0.92	0.23	0.49	0.61	-0.23	0.79	0.67	-0.32	0.86	0.76		0.87	0.87	0.79	-0.03	0.65	0.97	0.88
Total Liab	0.65	0.74	0.91	0.62	0.11	0.98	0.54	-0.19	-0.93	0.09	0.24	0.63	-0.23	0.62	0.53	-0.29	1.0	0.79	0.87		0.99	0.62	0.01	0.48	0.91	0.81
Property Plant And Equipment Gross	0.64	0.72	0.91	0.6	0.11	0.98	0.52	-0.26	-0.92	0.08	0.3	0.59	-0.26	0.62	0.54	-0.25	0.99	0.79	0.87	0.99		0.63	0.0	0.49	0.91	0.81
Total Current Assets	0.99	0.62	0.57	0.83	0.83	0.67	0.82	-0.68	-0.72	0.52	0.7	0.8	-0.16	1.0	0.79	-0.47	0.6	0.76	0.79	0.62	0.63		0.42	0.79	0.67	0.93
Short Term Debt	0.45	0.26	-0.09	0.32	0.6	-0.01	0.18	-0.06	-0.07	0.26	0.07	0.48	-0.31	0.42	0.44	-0.21	-0.02	0.42	-0.03	0.01	0.0	0.42		0.47	-0.09	0.41
Common Stock	0.79	0.3	0.46	0.7	0.68	0.52	0.68	-0.44	-0.6	0.41	0.45	0.68	-0.66	0.79	0.98	-0.03	0.46	0.59	0.65	0.48	0.49	0.79	0.47		0.55	0.79
Other Liab	0.66	0.57	0.97	0.63	0.2	0.89	0.59	-0.3	-0.94	0.09	0.33	0.52	-0.25	0.66	0.59	-0.27	0.9	0.75	0.97	0.91	0.91	0.67	-0.09	0.55		0.81
Net Tangible Assets	0.93	0.64	0.78	0.85	0.64	0.8	0.76	-0.46	-0.89	0.46	0.5	0.76	-0.27	0.93	0.8	-0.43	0.78	0.91	0.88	0.81	0.81	0.93	0.41	0.79	0.81

Click cells to compare fundamentals

AnaptysBio Account Relationship Matchups

AnaptysBio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	435.2M	416.6M	643.1M	610.4M	452.4M	354.3M
Short Long Term Debt Total	2.2M	342K	21.0M	19.5M	17.8M	10.8M
Other Current Liab	871K	15.3M	12.9M	21.6M	31.0M	32.5M
Total Current Liabilities	29.5M	19.8M	16.1M	26.1M	37.4M	19.3M
Total Stockholder Equity	405.0M	396.7M	356.4M	262.1M	88.1M	83.7M
Property Plant And Equipment Net	1.6M	1.8M	21.8M	20.0M	18.3M	19.2M
Net Debt	(168.8M)	(250.1M)	(474.8M)	(51.9M)	(18.2M)	(19.1M)
Retained Earnings	(244.0M)	(264.0M)	(321.8M)	(450.5M)	(614.1M)	(583.4M)
Accounts Payable	16.2M	4.2M	1.7M	2.8M	4.7M	4.2M
Cash	171.0M	250.5M	495.7M	71.3M	36.0M	34.2M
Non Current Assets Total	57.5M	20.0M	89.2M	163.2M	45.6M	53.5M
Non Currrent Assets Other	208K	1.5M	662K	256K	230.4K	218.9K
Cash And Short Term Investments	374.2M	393.7M	548.1M	441.2M	390.9M	295.2M
Common Stock Shares Outstanding	27.1M	27.3M	27.4M	28.2M	26.9M	21.0M
Liabilities And Stockholders Equity	435.2M	416.6M	643.1M	610.4M	452.4M	354.3M
Non Current Liabilities Total	654K	4.6M	270.5M	322.2M	326.8M	343.2M
Other Current Assets	3.5M	2.9M	4.9M	4.5M	9.1M	9.5M
Other Stockholder Equity	213.5M	660.7M	678.6M	717.8M	703.0M	738.1M
Total Liab	30.2M	19.8M	286.6M	348.3M	364.3M	382.5M
Property Plant And Equipment Gross	1.6M	1.8M	21.8M	20.0M	24.5M	25.7M
Total Current Assets	377.7M	396.6M	553.9M	447.2M	406.8M	300.8M
Accumulated Other Comprehensive Income	338K	(4K)	(422K)	(5.2M)	(797K)	(836.9K)
Short Term Debt	2.2M	342K	1.5M	1.6M	1.8M	2.3M
Other Liab	796K	654K	251.1M	304.4M	350.1M	367.6M
Net Tangible Assets	405.0M	396.7M	627.0M	584.3M	672.0M	705.6M
Other Assets	208K	139K	18.2M	256K	294.4K	279.7K
Property Plant Equipment	3.0M	1.8M	2.3M	2.1M	2.4M	1.6M
Capital Surpluse	648.7M	660.7M	678.6M	717.8M	825.5M	517.6M
Retained Earnings Total Equity	(244.0M)	(264.0M)	(321.8M)	(450.5M)	(405.4M)	(385.2M)
Short Term Investments	203.2M	143.2M	52.4M	369.9M	354.9M	252.1M
Capital Lease Obligations	871K	342K	21.0M	19.5M	17.8M	9.4M
Net Invested Capital	406.4M	396.7M	356.4M	262.1M	88.1M	83.7M
Long Term Investments	54.3M	17.5M	67.1M	142.9M	27.0M	25.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether AnaptysBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AnaptysBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anaptysbio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anaptysbio Stock:

How To Invest In AnaptysBio

Details

Is AnaptysBio Stock a good investment?

Details

What is AnaptysBio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.

Note that the AnaptysBio information on this page should be used as a complementary analysis to other AnaptysBio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for AnaptysBio Stock analysis

When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Transaction History View history of all your transactions and understand their impact on performance
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

Is AnaptysBio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(6.14)

Revenue Per Share

0.862

Quarterly Revenue Growth

4.225

Return On Assets

(0.20)

Return On Equity

(1.37)

The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AnaptysBio Other Current Assets vs Property Plant And Equipment Net Analysis

Other Current Assets vs Property Plant And Equipment Net

Other Current Assets vs Property Plant And Equipment Net Correlation Analysis

Correlation Coefficient

Other Current Assets

Property Plant And Equipment Net

AnaptysBio fundamental ratios Correlations

AnaptysBio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AnaptysBio fundamental ratios Accounts

Also Currently Popular

Complementary Tools for AnaptysBio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 1.0	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.99	Total Liab

Cash	- 1.0	Net Debt
Retained Earnings	- 0.96	Other Current Liab
Other Liab	- 0.94	Retained Earnings
Total Liab	- 0.93	Retained Earnings
Property Plant And Equipment Gross	- 0.92	Retained Earnings
Other Stockholder Equity	- 0.92	Retained Earnings